{"title":"分子三维度量在片段空间和其他空间的比较分析。","authors":"Tom Dekker, Maikel Wijtmans, Iwan J.P. de Esch","doi":"10.1016/j.drudis.2025.104443","DOIUrl":null,"url":null,"abstract":"<div><div>Within the fragment-based drug discovery (FBDD) community, there is growing interest in developing non-planar, 3D screening fragments to complement the predominantly 2D structures that currently populate fragment libraries. Molecular three-dimensionality is typically evaluated using metrics such as the fraction of sp<sup>3</sup>-hybridized carbon atoms (F<sub>C</sub>sp<sup>3</sup>), plane of best fit (PBF) and/or principal moment of inertia (PMI). In this study, we review these 3D metrics and perform systematic cheminformatic analyses. Furthermore, we explore the use of alternative metrics that consider atom hybridization for the assessment of molecular shape. Although our analysis is grounded in a fragment-based context, the insights gained are broadly applicable across the drug discovery phases.</div></div>","PeriodicalId":301,"journal":{"name":"Drug Discovery Today","volume":"30 9","pages":"Article 104443"},"PeriodicalIF":7.5000,"publicationDate":"2025-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Comparative analysis of molecular 3D metrics in fragment space and beyond\",\"authors\":\"Tom Dekker, Maikel Wijtmans, Iwan J.P. de Esch\",\"doi\":\"10.1016/j.drudis.2025.104443\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Within the fragment-based drug discovery (FBDD) community, there is growing interest in developing non-planar, 3D screening fragments to complement the predominantly 2D structures that currently populate fragment libraries. Molecular three-dimensionality is typically evaluated using metrics such as the fraction of sp<sup>3</sup>-hybridized carbon atoms (F<sub>C</sub>sp<sup>3</sup>), plane of best fit (PBF) and/or principal moment of inertia (PMI). In this study, we review these 3D metrics and perform systematic cheminformatic analyses. Furthermore, we explore the use of alternative metrics that consider atom hybridization for the assessment of molecular shape. Although our analysis is grounded in a fragment-based context, the insights gained are broadly applicable across the drug discovery phases.</div></div>\",\"PeriodicalId\":301,\"journal\":{\"name\":\"Drug Discovery Today\",\"volume\":\"30 9\",\"pages\":\"Article 104443\"},\"PeriodicalIF\":7.5000,\"publicationDate\":\"2025-07-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Drug Discovery Today\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1359644625001564\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Discovery Today","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1359644625001564","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
Comparative analysis of molecular 3D metrics in fragment space and beyond
Within the fragment-based drug discovery (FBDD) community, there is growing interest in developing non-planar, 3D screening fragments to complement the predominantly 2D structures that currently populate fragment libraries. Molecular three-dimensionality is typically evaluated using metrics such as the fraction of sp3-hybridized carbon atoms (FCsp3), plane of best fit (PBF) and/or principal moment of inertia (PMI). In this study, we review these 3D metrics and perform systematic cheminformatic analyses. Furthermore, we explore the use of alternative metrics that consider atom hybridization for the assessment of molecular shape. Although our analysis is grounded in a fragment-based context, the insights gained are broadly applicable across the drug discovery phases.
期刊介绍:
Drug Discovery Today delivers informed and highly current reviews for the discovery community. The magazine addresses not only the rapid scientific developments in drug discovery associated technologies but also the management, commercial and regulatory issues that increasingly play a part in how R&D is planned, structured and executed.
Features include comment by international experts, news and analysis of important developments, reviews of key scientific and strategic issues, overviews of recent progress in specific therapeutic areas and conference reports.